Home » Market News » DirectorsTalk Highlights » Look At Her Now: Selena Gomez
Immupharma Plc

Look At Her Now: Selena Gomez

Selena Gomez is back, and fans couldn’t be happier.

It’s a triumphant return for Selena, who has suffered through health issues and break-ups over the past two years – but nothing can hold this girl down.

Selena lives with the autoimmune disease Lupus, which causes inflammation to the joints, skin and other organs, and in 2017, she was forced to undergo a kidney transplant due to the damage caused to her kidney.

In September 2017, the Hands To Myself singer revealed she had a transplant earlier that year, with her friend Francia Raisa donating a kidney after discovering she was a match.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.